Advertisement
Screener

TransMedics Group, Inc. (TMDX) Debt / Equity

TransMedics Group, Inc. Debt/Equity Ratio

The debt/equity ratio shows how much a company has borrowed for every dollar its shareholders have put in. It is long-term debt, both the part due within a year and the rest, divided by shareholder equity, shown as a multiple with both amounts in the table. A higher ratio means the company relies more on borrowed money than on shareholder capital. Because equity shrinks through buybacks or losses, the ratio can rise even when debt is unchanged, and it has no meaning when equity is negative. Quarterly points use quarter-end balances; annual points use fiscal-year-end balances.

  • TransMedics Group, Inc. debt/equity ratio for the quarter ending 2021-03-31 was 0.36, a 51.48% decline year-over-year.
  • TransMedics Group, Inc. debt/equity ratio for the quarter ending 2020-09-30 was 0.32.
  • TransMedics Group, Inc. debt/equity ratio for the quarter ending 2020-06-30 was 0.3.
  • TransMedics Group, Inc. debt/equity ratio for the quarter ending 2020-03-31 was 0.73.
Available history
2020-03-31 to 2021-03-31
Data captured

Historical Debt/Equity Ratio

DateDebt/Equity RatioLong-term debtShareholder equity
2021-03-310.36$34.79M$97.68M
2020-09-300.32$34.53M$109.55M
2020-06-300.3$34.4M$113.76M
2020-03-310.73$34.27M$46.68M

Annual Debt/Equity Ratio

DateDebt/Equity RatioLong-term debtShareholder equity

Similar stocks

Stock NameCountryMarket CapPE Ratio
Axogen, Inc. (AXGN)United States$2.329B-73.83
BIOLIFE SOLUTIONS INC (BLFS)United States$1.887B23.80
LivaNova PLC (LIVN)$4.158B24.01
Integer Holdings Corp (ITGR)United States$4.289B25.17
CONMED Corp (CNMD)United States$1.353B26.72
Ceribell, Inc. (CBLL)United States$0.916B-11.27
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53